Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Endocrine 2

Conditions

Thyroid Cancer, Papillary 2Thyroid Diseases 1Hypothyroidism 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 64Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Thyroid (USP) × Head & Neck × Clear all
NCT07239674 2025-11-20

DELTA

West China Hospital

Phase 3 Not yet recruiting
646 enrolled
Head & Neck

Thyroid Diseases

NCT05247476 2022-02-18

Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.

Zhongshan Hospital Xiamen University

Phase 4 Unknown
50 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Hypothyroidism

NCT01974284 2019-11-25

Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma

Yale University

Phase NA Terminated
7 enrolled 4 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡